Sentences with phrase «gene sequencing company»

Not exact matches

Another company, Perfect Day, is applying gene sequencing and 3D printing to create milk without the cow.

You need the oligonucleotides to stitch genes together, and as far as I know, most companies will check the order if the sequence represents that of a dangerous virus.»

However, the results of more recent phylogenetic analyses, derived from comparisons between sequences of specific genes and of whole genomes, seemed to point to Ctenophora as the first group that parted company with the lineage from which the rest of the animal kingdom (including sponges) evolved.

The latest gene - sequencing technologies developed by biotech companies 454 Life Sciences and Illumina can analyze several million DNA fragments at a time.

For over half (54 %) of the 39 companies, it was impossible to find out which gene sequences and variants would be tested, because this information wasn't provided.

One of the core beliefs at ISB is that medicine will become more and more personalized, with people sequencing their own genes and pharmaceutical companies developing drugs for groups with certain genetic characteristics.

The bioethics commission, chaired by Amy Gutmann, president of the University of Pennsylvania, argues that physicians, researchers, and companies marketing DNA tests need to reframe how they think about all of this: While of course no one knows what will be buried in a given gene sequence, the fact that ancillary findings may be part of it should hardly be a surprise.

The company, Human Genome Sciences Inc. (HGS) in Rockville, Maryland, found the gene by sequencing human DNA and searching databases for possible genes; it didn't know there was a link to AIDS when it filed a patent application in 1995.

He says HGS was getting «diminishing returns» from its investment in TIGR since Venter had steered his outfit into sequencing organisms of little medical importance, and into human genome sequencing, also of limited value for a company like HGS that is interested in genes as drug targets (not untranslated DNA that makes up most of the genome).

The case highlights concerns that a network of individual gene patents could threaten the future of personalized medicine and whole - genome sequencing by blocking companies and clinicians from reporting a patient's genetic risk factors for different diseases.

The court ruled that companies can obtain patents on the genes but can not patent methods to compare those gene sequences.

deCODE has identified key variations in the sequence of the genome conferring increased risk of major public health challenges from cardiovascular disease to cancer, and employs its gene discovery engine to develop DNA - based tests to assess individual risk of common diseases; to license its tests and intellectual property to partners; and to provide comprehensive, leading - edge contract services to companies and research institutions around the globe.

Insurance companies and potential employers already make judgments about who they'll take on as a risk, and have already disqualified people because their gene sequence indicates they MIGHT develop a particular health problem.